About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Inflammatory Markers Detected in Blood Tests can Predict Mortality

Font : A-A+

Highlights
  • Inflammatory markers predict preclinical states of diseases or markers of future disease.
  • Interleukin-6, C-reactive protein and α1-acid glycoprotein are strong predictors of mortality.

Inflammatory Markers Detected in Blood Tests can Predict Mortality

Highlights

  • Inflammatory markers predict preclinical states of diseases or markers of future disease.
  • Interleukin-6, C-reactive protein and α1-acid glycoprotein are strong predictors of mortality.
An inflammatory marker detected in blood tests in middle-aged adults can better predict the risk of death compared with another similar biomarker.

Inflammatory markers are known to be associated with cancer, chronic heart disease and other serious health conditions. However, the marker that is most useful in predicting these diseases continues to be debated.

Advertisement


"Omics technologies are exciting, as they allow the concurrent assessment of many biomarkers, some of which may turn out to be important to detect preclinical states of diseases or be markers of future disease," states Prof. Archana Singh-Manoux, Inserm (France) and University College London (UK).

The authors looked at markers of inflammation such as interleukin-6 (IL-6), C-reactive protein (CRP) and α1-acid glycoprotein (AGP); the latter was found in a recent metabolomics study to be a strong predictor of death within 5 years.
Advertisement

The CMAJ study included data collected between 1997 and 1999 on 6545 men and women aged 45-69 years. Participants were followed to 2015 to determine if they had died.

"When a recent metabolomics study highlighted the importance of AGP, our question was how relevant is this marker when compared to other known inflammatory markers. The novelty of our approach lies in being able to assess risk of mortality in the short- and long-term. Our findings show IL-6, which is already known to be important to heart disease, to do better than AGP."

"Research on biomarkers is progressing fast, and it is important to undertake checks like in the one in our study, to shape future research on biomarkers," states Prof. Singh-Manoux.

In a related commentary, Dr. Paul Ridker, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, writes, "biomarker discovery is crucial for thinking about new treatment targets. With regard to AGP, CRP and IL-6, what remains uncertain is whether reducing inflammation can reduce cardiovascular event rates."

Source: Medindia

Citations   close

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Kidney
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Thalassemia Quiz on Depression Blood in Stools - Symptom Evaluation Bombay Blood Group 

Most Popular on Medindia

Diaphragmatic Hernia Vent Forte (Theophylline) Hearing Loss Calculator Noscaphene (Noscapine) Indian Medical Journals Color Blindness Calculator Accident and Trauma Care The Essence of Yoga Calculate Ideal Weight for Infants Nutam (400mg) (Piracetam)
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Inflammatory Markers Detected in Blood Tests can Predict Mortality Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests